Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase ; volume:37 ; number:24 ; year:2018 ; extent:19
The EMBO journal / European Molecular Biology Organization ; 37, Heft 24 (2018) (gesamt 19)

Creator: Muñoz, Ivan M.
Morgan, Michael E.
Peltier, Julien
Weiland, Florian
Gregorczyk, Mateusz
Brown, Fiona CM
Macartney, Thomas
Toth, Rachel
Trost, Matthias
Rouse, John

DOI: 10.15252/embj.201899559

URN: urn:nbn:de:101:1-2022090306272552161478

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Muñoz, Ivan M.
Morgan, Michael E.
Peltier, Julien
Weiland, Florian
Gregorczyk, Mateusz
Brown, Fiona CM
Macartney, Thomas
Toth, Rachel
Trost, Matthias
Rouse, John

Other Objects (12)

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Hochschulschrift

The cyclin dependent kinase 16 : regulation, interactions, substrates and physiological function

A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts

BioE3 identifies specific substrates of ubiquitin E3 ligases

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells

Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations

Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors

Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption

Screening of the ‘Stasis Box’ identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus

A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma

Hochschulschrift

α- and β-secretase in Alzheimer's disease: Identity and physiological substrates

Profluorescent substrates for the screening of olefin metathesis catalysts

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Hochschulschrift

The cyclin dependent kinase 16 : regulation, interactions, substrates and physiological function

A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts

BioE3 identifies specific substrates of ubiquitin E3 ligases

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells

Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations

Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors

Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption

Screening of the ‘Stasis Box’ identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus

A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma

Hochschulschrift

α- and β-secretase in Alzheimer's disease: Identity and physiological substrates

Profluorescent substrates for the screening of olefin metathesis catalysts

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Hochschulschrift

The cyclin dependent kinase 16 : regulation, interactions, substrates and physiological function

A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts

BioE3 identifies specific substrates of ubiquitin E3 ligases

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells

Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations

Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors

Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption

Screening of the ‘Stasis Box’ identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus

A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma

Hochschulschrift

α- and β-secretase in Alzheimer's disease: Identity and physiological substrates

Profluorescent substrates for the screening of olefin metathesis catalysts

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

The cyclin dependent kinase 16 : regulation, interactions, substrates and physiological function

A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts

BioE3 identifies specific substrates of ubiquitin E3 ligases

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells

Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations

Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors

Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption

Screening of the ‘Stasis Box’ identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus

A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma

α- and β-secretase in Alzheimer's disease: Identity and physiological substrates

Profluorescent substrates for the screening of olefin metathesis catalysts

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

The cyclin dependent kinase 16 : regulation, interactions, substrates and physiological function

A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts

BioE3 identifies specific substrates of ubiquitin E3 ligases

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells

Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations

Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors

Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption

Screening of the ‘Stasis Box’ identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus

A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma

α- and β-secretase in Alzheimer's disease: Identity and physiological substrates

Profluorescent substrates for the screening of olefin metathesis catalysts

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

The cyclin dependent kinase 16 : regulation, interactions, substrates and physiological function

A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts

BioE3 identifies specific substrates of ubiquitin E3 ligases

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells

Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations

Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors

Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption

Screening of the ‘Stasis Box’ identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus

A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma

α- and β-secretase in Alzheimer's disease: Identity and physiological substrates

Profluorescent substrates for the screening of olefin metathesis catalysts

Related objects

Reset password